Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Mark E. Gurney Patents
Inventor:
Gurney; Mark E.
Address:
Grand Rapids, MI
No. of patents:
23
Patents:




Patent Number Title Of Patent Date Issued
7378511 Alzheimer's disease secretase, APP substrates therefor, and uses therefor May 27, 2008
The present invention provides the enzyme and enzymatic procedures for cleaving the .beta. secretase cleavage site of the APP protein and associated nucleic acids, peptides, vectors, cells and cell isolates and assays. The invention further provides a modified APP protein and associa
7375187 Alzheimer's disease secretase, APP substrates therefor, and uses therefor May 20, 2008
The present invention provides the enzyme and enzymatic procedures for cleaving the .beta. secretase cleavage site of the APP protein and associated nucleic acids, peptides, vectors, cells and cell isolates and assays. The invention further provides a modified APP protein and associa
7368536 Alzheimer's disease secretase, APP substrates therefor, and uses therefor May 6, 2008
The present invention provides the enzyme and enzymatic procedures for cleaving the .beta. secretase cleavage site of the APP protein and associated nucleic acids, peptides, vectors, cells and cell isolates and assays. The invention further provides a modified APP protein and associa
7309811 Transgenic mice knockouts of BACE-1 December 18, 2007
The invention provides transgenic animals that are heterozygous or homozygous for a nonfunctional allele of BACE-1. These animals show normal development indicating that BACE-1 is not necessary for development and hence is an appropriate therapeutic target. The transgenic animals are
7205120 Substrates and assays for .beta.-secretase activity April 17, 2007
The present invention is directed to novel substrates for Hu-Asp. More particularly, the invention provides peptide substrates and fusion polypeptide substrates comprising a .beta.-secretase cleavage site. Methods and compositions for making and using the peptides are disclosed.
7041473 Alzheimer's disease secretase, APP substrates therefor, and uses thereof May 9, 2006
The present invention provides the enzyme and enzymatic procedures for cleaving the .beta. secretase cleavage site of the APP protein and associated nucleic acids, peptides, vectors, cell and cell isolates and assays. The invention further provides a modified APP protein and associat
6913918 Alzheimer's disease secretase, APP substrates therefor, and uses therefor July 5, 2005
The present invention provides the enzyme and enzymatic procedures for cleaving the .beta. secretase cleavage site of the APP protein and associated nucleic acids, peptides, vectors, cells and cell isolates and assays. The invention further provides a modified APP protein and associa
6867018 Alzheimer's disease secretase, APP substrates therefor, and uses thereof March 15, 2005
The present invention provides the enzyme and enzymatic procedures for cleaving the .beta. secretase cleavage site of the APP protein and associated nucleic acids, peptides, vectors, cells and cell isolates and assays. The invention further provides a modified APP protein and associa
6835565 Alzheimer's disease secretase December 28, 2004
The present invention provides the enzyme and enzymatic procedures for cleaving the .beta. secretase cleavage site of the APP protein and associated nucleic acids, peptides, vectors, cells and cell isolates and assays.
6828117 Alzheimer's disease secretase, APP substrates therefor, and uses therefor December 7, 2004
The present invention provides the enzyme and enzymatic procedures for cleaving the .beta. secretase cleavage site of the APP protein and associated nucleic acids, peptides, vectors, cells and cell isolates and assays. The invention further provides a modified APP protein and associa
6825023 Alzheimer's disease secretase, APP substrates therefor, and uses therefor November 30, 2004
The present invention provides the enzyme and enzymatic procedures for cleaving the .beta. secretase cleavage site of the APP protein and associated nucleic acids, peptides, vectors, cells and cell isolates and assays. The invention further provides a modified APP protein and associa
6797487 Polynucleotides encoding alzheimer's disease secretase September 28, 2004
The present invention provides methods of reducing cellular production of amyloid beta (A.beta.) from amyloid precursor protein (APP) by reducing Asp2 transcription or translation in cells.
6790610 Alzheimer's disease, secretase, APP substrates therefor, and uses therefor September 14, 2004
The present invention provides the enzyme and enzymatic procedures for cleaving the .beta. secretase cleavage site of the APP protein and associated nucleic acids, peptides, vectors, cells and cell isolates and assays. The invention further provides a modified APP protein and associa
6753163 Alzheimer's disease secretase, APP substrates therefor, and uses therefor June 22, 2004
The present invention provides the enzyme and enzymatic procedures for cleaving the .beta. secretase cleavage site of the APP protein and associated nucleic acids, peptides, vectors, cells and cell isolates and assays. The invention further provides a modified APP protein and associa
6737510 Alzheimer's disease secretase, APP substrates therefor, and uses thereof May 18, 2004
The present invention provides the enzyme and enzymatic procedures for cleaving the .beta. secretase cleavage site of the APP protein and associated nucleic acids, peptides, vectors, cells and cell isolates and assays. The invention further provides a modified APP protein and associa
6730778 Human sel-10 polypeptides and polynucleotides that encode them May 4, 2004
The present invention provides isolated nucleic acid molecules comprising a polynucleotide encoding either of two alternative splice variants of human sel-10, one of which is expressed in hippocampal cells, and one of which is expressed in mammary cells. The invention also provides isola
6727074 Alzheimer's disease secretase, APP substrates therefor, and uses therefor April 27, 2004
The present invention provides the enzyme and enzymatic procedures for cleaving the .beta. secretase cleavage site of the APP protein and associated nucleic acids, peptides, vectors, cells and cell isolates and assays. The invention further provides a modified APP protein and associa
6706485 Method of identifying agents that inhibit APP processing activity March 16, 2004
The present invention provides methods of identifying agents that inhibit the amyloid precursor protein (APP) processing activity of Asp2 polypeptide.
6699671 Alzheimer's disease secretase, APP substrates therefor, and uses therefor March 2, 2004
The present invention provides the enzyme and enzymatic procedures for cleaving the .beta. secretase cleavage site of the APP protein and associated nucleic acids, peptides, vectors, cells and cell isolates and assays. The invention further provides a modified APP protein and associa
6638731 Human sel-10 polypeptides and polynucleotides that encode them October 28, 2003
The present invention provides isolated nucleic acid molecules comprising a polynucleotide encoding either of two alternative splice variants of human sel-10, one of which is expressed in hippocampal cells, and one of which is expressed in mammary cells. The invention also provides isola
6500667 Aspartyl protease 2 (Asp2) antisense oligonucleotides December 31, 2002
The present invention provides the enzyme and enzymatic procedures for cleaving the .beta. secretase cleavage site of the APP protein and associated nucleic acids, peptides, vectors, cells and cell isolates and assays. The invention further provides a modified APP protein and associa
6440698 Alzheimer's disease secretase, APP substrates therefor, and uses therefor August 27, 2002
The present invention provides the enzyme and enzymatic procedures for cleaving the .beta. secretase cleavage site of the APP protein and associated nucleic acids, peptides, vectors, cells and cell isolates and assays. The invention further provides a modified APP protein and associa
6420534 Alzheimer's disease secretase, APP substrates therefor, and uses thereof July 16, 2002
The present invention provides the enzyme and enzymatic procedures for cleaving the .beta. secretase cleavage site of the APP protein and associated nucleic acids, peptides, vectors, cells and cell isolates and assays. The invention further provides a modified APP protein and associa


 
 
  Recently Added Patents
Substituted 1H-pyrrolo[3,2-b, 3,2-c, and 2,3-c]pyridine-2-carboxamides and related analogs as inhibitors of casein kinase lepsilon
CMOS image sensor and fabricating method thereof
Flash curing in selective deposition modeling
Apparatus for everting a lining material
Thermal docking station for electronics
Galois field multiplier array for use within a finite field arithmetic unit
Clip for joining structural parts and fastening systems using a clip
  Randomly Featured Patents
High withstand voltage semiconductor device with shallow grooves between semiconductor region and field limiting rings with outer mesa groove
Powdered metal casing for perforating charge and its method of manufacture
Electrochemiluminescence of rare earth metal chelates
Mining method and apparatus
Use of proteins as anti-diabetes agents
Dahlia plant named `Dapasuje`
Camera
Cable sleeve liner
Chlorine-free silver protective lubricant composition (III)
Movable contact unit with operating projections, method of mounting operating projections and operating panel switch using movable contact unit with operating projections